Genome-Wide Prediction of Vaccine Candidates for Leishmania major: An Integrated Approach

Table 4

The distribution of fractional immunogenicity for the 60 optimal epitopes against the population of Southwest Asia.

S. number	Epitope	Fraction of overall immunogenicity	Covered alleles
1	SLWSLLAGV	0.07	A0201
2	LPRLFLAFL	0.06	B0702 B0801 B3501 Cw0401 Cw0602
3	YLLDGDQLI	0.05	A0201 A0205
4	GYPNINTYL	0.05	A2402 Cw0401
5	LYLLLPFLL	0.05	A2402 Cw0401
6	YMDPGAAGY	0.05	A0101
7	TPRIPLDSL	0.05	B0702 B0801 B3501 Cw0401
8	SPTPLLAAL	0.04	B0702 B3501 Cw0401 Cw0602 Cw0702
9	SFDDYTMVL	0.04	A2402 B3801 Cw0401
10	GYIVVDKYF	0.03	A2402
11	VLVGVVLGV	0.03	A0201
12	TLFPIDVTV	0.03	A0201
13	FIDANTAIY	0.03	A0101
14	FLFSPTDTL	0.02	A0201 A0205
15	LMAAMLVAV	0.02	A0201
16	APNYYLTPL	0.02	B0702 B3501 Cw0401
17	SLFRVANCK	0.02	A0301
18	LFLLVIYAF	0.02	A2402 Cw0401
19	MLPDMTCSL	0.02	A0201 A0205
20	ELRRRGQEV	0.02	B0801
21	LFGAFLFAF	0.02	Cw0401 Cw0702
22	LVHAGIAGK	0.02	A1101 A6801
23	FPISKGAAL	0.02	B0702 B0801 B3501
24	RPRLFARAI	0.01	B0702 B3501 B5101
25	STQPPVSSW	0.01	B5801
26	GYMPTASFK	0.01	A1101
27	APAAPHSPL	0.01	B0702 B3501
28	LTSAINQFW	0.01	B5801
29	IHPERTVAL	0.01	B3801
30	VESGALFSF	0.01	B4403
31	YQLTGTPVL	0.01	A0205 B5201
32	GTFAAPLRW	0.01	B5801
33	YVVDSYDGL	0.01	A0205
34	APALYTISL	0.01	B0702 B3501
35	APAHGSVSL	0.01	B0702 B3501
36	AYFVVPLEM	0.01	A2402
37	KHLLMAAML	0.01	B3801 Cw0602
38	FVRVWDRSL	0.01	B0702 B0801
39	AHAPQNAAL	0.01	B3801
40	ALYTSIPVR	0.01	A0301
41	MSLFVSTLF	0.01	B5801
42	TPSSARLSM	0.01	B0702 B3501
43	STVLRLFSF	0.01	B5801
44	VSGGSTVSF	0.01	B5801
45	SAAAPYSLW	0.01	B5801
46	NLAAGQSLK	<0.01	A0301
47	TMPTAPSSK	<0.01	A0301
48	CESGYALTV	<0.01	B4006
49	VSAQTIDDY	<0.01	Cw0702
50	YLCDRTTAA	<0.01	A0201
51	RELQSVYLL	<0.01	B4006 B4403
52	RIKRNWQKK	<0.01	A1101
53	HVARQLASY	<0.01	Cw0702
54	SVVDPMQNY	<0.01	Cw0702
55	AMKDPYTNY	<0.01	Cw0702
56	LLPRLFLAF	<0.01	A0301
57	REWYSADVL	<0.01	B4006
58	YTISLNPLL	<0.01	Cw0602
59	VRAPFTIQL	<0.01	Cw0602
60	KSSALAHKL	<0.01	Cw0602